Royal Bank of Canada Portfolio holdings
Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BPY
Brookfield Property Partners L.P. Limited Partnership Units
BPY
|
+$221M |
| 2 |
Gilead Sciences
GILD
|
+$146M |
| 3 |
Deutsche Bank
DB
|
+$137M |
| 4 |
Brookfield
BN
|
+$132M |
| 5 |
Brookfield Infrastructure Partners
BIP
|
+$118M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$214M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$149M |
| 3 |
Suncor Energy
SU
|
+$144M |
| 4 |
Canadian Natural Resources
CNQ
|
+$139M |
| 5 |
Verizon
VZ
|
+$100M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 26.02% |
| 2 | Energy | 12.2% |
| 3 | Industrials | 8.68% |
| 4 | Communication Services | 7.05% |
| 5 | Healthcare | 6.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CMA
2001
DELISTED
Comerica
CMA
| $2.75M | ﹤0.01% |
53,661
-6,533
| -11% | -$318K |
|
|
SIR
2002
DELISTED
SELECT INCOME REIT
SIR
| $2.75M | ﹤0.01% |
303,201
+220,286
| +266% | +$2.25M |
|
2003
iShares 0-5 Year Investment Grade Corporate Bond ETF
SLQD
$2.38B
| $2.74M | ﹤0.01% |
54,420
-838
| -2% | -$42.4K |
|
|
ESV
2004
DELISTED
Ensco Rowan plc
ESV
| $2.74M | ﹤0.01% |
30,755
-9,425
| -23% | -$917K |
|
2005
Fortune Brands Innovations
FBIN
$5.75B
| $2.74M | ﹤0.01% |
69,890
-35,610
| -34% | -$1.39M |
|
2006
Jazz Pharmaceuticals
JAZZ
$15.8B
| $2.74M | ﹤0.01% |
15,546
+1,872
| +14% | +$336K |
|
2007
Motorola Solutions
MSI
$77B
| $2.73M | ﹤0.01% |
47,670
+17,794
| +60% | +$1.07M |
|
2008
STMicroelectronics
STM
$49B
| $2.73M | ﹤0.01% |
336,627
+11,221
| +3% | +$96.2K |
|
2009
First Trust NASDAQ 100 ex-Technology Sector Index Fund
QQXT
$161M
| $2.73M | ﹤0.01% |
65,182
+8,674
| +15% | +$366K |
|
|
PAMT
2010
PAMT Corp
PAMT
$289M
| $2.73M | ﹤0.01% |
188,112
+184
| +0.1% | +$2.72K |
|
2011
Federated Hermes
FHI
$4.71B
| $2.73M | ﹤0.01% |
81,416
+12,028
| +17% | +$415K |
|
|
GRX
2012
Gabelli Healthcare & Wellness Trust
GRX
$146M
| $2.72M | ﹤0.01% |
242,060
-6,521
| -3% | -$73.5K |
|
|
PMC
2013
DELISTED
PharMerica Corporation
PMC
| $2.71M | ﹤0.01% |
81,537
+4,866
| +6% | +$149K |
|
2014
Invesco Dorsey Wright Healthcare Momentum ETF
PTH
$241M
| $2.71M | ﹤0.01% |
128,154
+29,718
| +30% | +$614K |
|
|
GEQ
2015
DELISTED
Gugnheim Eql Wght Enh Eqty In Fd
GEQ
| $2.71M | ﹤0.01% |
147,274
-6,613
| -4% | -$129K |
|
|
FIG
2016
DELISTED
Fortress Investment Group Llc
FIG
| $2.71M | ﹤0.01% |
371,457
+13,282
| +4% | +$106K |
|
2017
State Street SPDR S&P Global Infrastructure ETF
GII
$930M
| $2.7M | ﹤0.01% |
57,983
-36,991
| -39% | -$1.83M |
|
2018
Invesco S&P Spin-Off ETF
CSD
$236M
| $2.7M | ﹤0.01% |
58,936
-51,390
| -47% | -$2.45M |
|
2019
iShares Morningstar Small-Cap Growth ETF
ISCG
$1.02B
| $2.7M | ﹤0.01% |
111,666
-5,010
| -4% | -$121K |
|
2020
VanEck Agribusiness ETF
MOO
$978M
| $2.68M | ﹤0.01% |
48,584
-137,002
| -74% | -$7.64M |
|
|
BWP
2021
DELISTED
Boardwalk Pipeline Partners
BWP
| $2.68M | ﹤0.01% |
184,383
-47,038
| -20% | -$763K |
|
2022
Marten Transport
MRTN
$1.24B
| $2.68M | ﹤0.01% |
308,213
+29,928
| +11% | +$272K |
|
2023
ProShares Short 20+ Year Treasury ETF
TBF
$106M
| $2.67M | ﹤0.01% |
101,953
+42,753
| +72% | +$1.08M |
|
2024
Invesco Bloomberg MVP Multi-factor ETF
BMVP
$107M
| $2.67M | ﹤0.01% |
105,618
-133,053
| -56% | -$3.37M |
|
2025
Rayonier
RYN
$6.59B
| $2.67M | ﹤0.01% |
115,317
-11,100
| -9% | -$261K |
|
Similar funds
Royal Bank of Canada's Q2 2015 Portfolio in Review
As of Q2 2015, Royal Bank of Canada held 6,992 positions worth $145B, up 1% from $143B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Royal Bank of Canada's Q2 2015 filing shows 745 new, 3,148 increased, 2,112 reduced and 299 closed positions. Its largest new stake was Concordia International Corp. Common Stock: 309,256 shares worth $22.3M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $214M.
By sector, the portfolio is most concentrated in Financials at 26% of assets, up from 25% a quarter earlier, followed by Energy and Industrials.
- Royal Bank of Canada's largest Q2 2015 buy was Concordia International Corp. Common Stock: 309,256 shares worth $22.3M.
- Royal Bank of Canada added most to Brookfield Property Partners L.P. Limited Partnership Units in Q2 2015, an estimated $221M increase.
- Royal Bank of Canada's biggest Q2 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $214M.
- Royal Bank of Canada fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $55M.
- Royal Bank of Canada's ten largest holdings make up 25% of its $145B portfolio in Q2 2015.
- Royal Bank of Canada opened 745 new positions and closed 299 in Q2 2015.
- Royal Bank of Canada's portfolio value rose 1% quarter-over-quarter to $145B.
Based on Royal Bank of Canada's 13F filing for Q2 2015, filed 14 Aug 2015.